Results of Operations
We have neither engaged in any operations nor generated any operating revenues to date. Our only activities for the period from April 1, 2022, through September 30, 2022 were organizational activities, after IPO related to identifying a target company for a business combination. We do not expect to generate any operating revenues until after the completion of our initial business combination. We generate non-operating income in the form of interest income on cash and cash equivalents held after the Initial Public Offering. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.
For the three months ended September 30, 2022, we had a net loss of $318,625, which resulted from franchise tax and income tax expense of $111,853, formation and operating costs of $606,737 and was offset in part by a change in the fair value of our warrant liability of $31,876 and interest and dividend income on investments held in the trust account of $368,089.
For the three months ended September 30, 2021, we had a net loss of $1,349,179, which resulted from franchise tax and income tax expense of $141,370, formation and operating costs of $92,422, stock based compensation expense of $1,351,448, and was offset in part by a change in the fair value of our warrant liability of $239,070, expensed offering cost of $4,926 and interest and dividend income on investments held in the trust account of $1,917.
For the six months ended September 30, 2022, we had a net loss of $523,297, which resulted from franchise tax and income tax expense of $192,806, formation and operating costs of $1,128,702 and was offset in part by a change in the fair value of our warrant liability of $119,535 and interest and dividend income on investments held in the trust account of $678,676.
For the six months ended September 30, 2021, we had a net loss of $1,350,043, which resulted from franchise tax and income tax expense of $141,370, formation and operating costs of $93,286, stock based compensation expense of $1,351,448, and was offset in part by a change in the fair value of our warrant liability of $239,070, expensed offering cost of $4,926 and interest and dividend income on investments held in the trust account of $1,917.
Liquidity and Capital Resources
As of September 30, 2022, we had $80,645 in our operating bank account available for working capital needs. All remaining cash was held in the trust account and is generally unavailable for our use prior to an initial business combination.
On August 2, 2021, we consummated the Initial Public Offering of 20,000,000 units (the “Units”), at $10.00 per Unit, generating gross proceeds of $200,000,000. Each Unit consists of one share of common stock (“Public Share”), one right (“Public Right”) and one redeemable warrant (“Public Warrant”). Each Public Right entitles the holder to receive one-twentieth of one share of common stock at the closing of our initial business combination. Each Public Warrant entitles the holder to purchase three-fourths of one share of common stock at an exercise price of $11.50 per whole share.
Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 714,400 units (the “Private Units”), at a price of $10.00 per Private Unit ($7,144,000 in the aggregate). Each Private Unit consists of one share of common stock (“Private Share”), one right (“Private Right”) and one warrant (“Private Warrant”). Each Private Right entitles the holder to receive one-twentieth of one share of common stock at the closing of our initial business combination. Each Private Warrant entitles the holder to purchase three-fourths of one share of common stock at an exercise price of $11.50 per whole share.
The proceeds from the Private Units was added to the proceeds from the Initial Public Offering to be held in the trust account. If we do not complete our initial business combination within 15 months (or up to 18 months if our time to complete a business combination is extended), the proceeds of the sale of the Private Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Units and all underlying securities will be worthless. There will be no redemption rights or liquidating distributions from the trust account with respect to the rights and warrants included in the Private Units.
On August 6, 2021, in connection with the underwriters’ exercise in full of their option to purchase up to 3,000,000 additional Units to cover over-allotments, if any, we consummated the sale of an additional 3,000,000 Units, at $10.00 per Unit, generating gross proceeds of $30,000,000.